Metraipolis › archive › dc_5ecffcbe19e3

[How I manage relapsed/refractory B-cell acute lymphoblastic leukemia patients treated with CD19 CAR- T cells throughout whole-process management] — Europe PMC PMID:41486655

Source
Europe PMC (chi)
Original
https://europepmc.org/article/MED/41486655
DOI
10.3760/cma.j.cn121090-20250910-00419
License (as archived)
solo-consultazione
Archived
2026-11-08T02:34:26.838Z
SHA-256 of the archived text
e2217ac9e1f9997815093c4248b404dc8766ae3b69292171cc2f281d16335fc2
Stable URL of this page
https://metraipolis.com/documento/dc_5ecffcbe19e3

How to cite

[How I manage relapsed/refractory B-cell acute lymphoblastic leukemia patients treated with CD19 CAR- T cells throughout whole-process management] — Europe PMC PMID:41486655 — Europe PMC (chi), https://europepmc.org/article/MED/41486655 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ecffcbe19e3 (Metraipolis archive dc_5ecffcbe19e3, sha256 e2217ac9e1f9997815093c4248b404dc8766ae3b69292171cc2f281d16335fc2)
BibTeX
@misc{dc5ecffcbe19e3,
  title = {[How I manage relapsed/refractory B-cell acute lymphoblastic leukemia patients treated with CD19 CAR- T cells throughout whole-process management] — Europe PMC PMID:41486655},
  howpublished = {Europe PMC (chi)},
  url = {https://europepmc.org/article/MED/41486655},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ecffcbe19e3; sha256 e2217ac9e1f9997815093c4248b404dc8766ae3b69292171cc2f281d16335fc2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41486655. Agents can read the archived copy with the MCP tool read_document.